SCR-LIP-000491 · Claim · machine-readable JSON →

In a review of lipedema-associated pain management, conservative treatments (complex decongestive therapy, manual lymphatic drainage, compression, diet) showed limited and debatable efficacy for pain, while microcannular tumescent liposuction reduced pain on VAS from 7.8±2.1 to 2.2±1.3 (n=111) with benefit sustained at 8-year follow-up, and was concluded to be the most effective treatment.

This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
very low (GRADE)
Evidence
1 source(s)
Dates
2026-11-17 → 2026-11-17

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17

Evidence over time

2021Cause and management of lipedema-associated pain (2021) · refining

Evidence (1)

Context (PECO)

Populationpatients with lipedema, primarily women
Conditionlipedema
Exposureconservative therapy (CDT, MLD, compression, diet) vs microcannular tumescent liposuction
Comparatorconservative treatment vs surgical treatment
Outcomepain reduction (VAS)
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log